NCT02610166

Brief Summary

Arthritis in children is a long-term illness and it can make a child's life very difficult. In children 8-11 years old, the child and their family work together to deal with the problems that arthritis can cause. Learning to cope with and manage the problems that come with arthritis can stop it from getting worse. It is important to create programs that teach children and families how to cope with and manage arthritis. This study will develop and test an online game that helps children learn how to better manage their arthritis. The goal of these studies is to test: (1) how easy to use and acceptable the online game is; and (2) if children who play the game feel less pain, have fewer limitations, and a better quality of life compared to children who do not play the game.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2016

Typical duration for not_applicable

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 20, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2016

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

June 18, 2019

Status Verified

June 1, 2019

Enrollment Period

3.2 years

First QC Date

November 17, 2015

Last Update Submit

June 17, 2019

Conditions

Outcome Measures

Primary Outcomes (5)

  • Participant Accrual

    This will be centrally tracked by the clinical research project coordinator (CRPC).

    8 weeks

  • Intervention Fidelity

    Any issues or difficulties encountered during implementation of the intervention, control strategy, or outcome measures will be tracked throughout the study by the CRPC. For example, issues from a technical standpoint (for example, game not downloading properly, participant requiring assistance using the technology) or logistics standpoint.

    8 weeks

  • Acceptability and Satisfaction with Intervention

    Immediately post-trial children and parents in the intervention group will rate their acceptability of and satisfaction with the game and 10-15 English and 10-15 French children and one of their parents will take part in a brief qualitative interview.

    8 weeks

  • Engagement with Intervention

    Analytics will be used to track patterns of website program usage ("number of interactions" \[clicks\]).

    8 weeks

  • Dropout Rates

    This will be centrally tracked by the clinical research project coordinator (CRPC).

    8 weeks

Secondary Outcomes (6)

  • Pain

    8 weeks

  • Pain-related Activity Limitations

    8 weeks

  • Health-related Quality of Life

    8 weeks

  • Self Efficacy

    8 weeks

  • JIA-specific Disease Knowledge

    8 weeks

  • +1 more secondary outcomes

Study Arms (2)

Game

EXPERIMENTAL

Access to the game.

Behavioral: Game

Usual Care

ACTIVE COMPARATOR

Control group.

Other: Usual Care

Interventions

GameBEHAVIORAL

In addition to standard medical care, children in the experimental group will receive the Match-3 game. The game will be designed for short individual gameplay sessions (as little as a few seconds), once to three times a day, over the course of 8 weeks, involving no more than 15 minutes per day in anticipated screen time. There is no way to "lose" the game. Through a structured series of daily interactions, the player will learn strategies and develop decision-making abilities that will assist with management of their own JIA. The Match 3 concept (similar to the game, Bejeweled) will require the player to successfully match the treatment strategy to the JIA symptom.

Game

Children in usual care group receive standard medical care.

Usual Care

Eligibility Criteria

Age8 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age ≥ 8 and ≤ 11 years of age
  • Diagnosed with JIA (minimum 3 months) using International League of Associations for Rheumatology classification criteria96
  • Active disease
  • Child and primary parent/caregiver are able to speak and read English or French
  • Participants are willing and able to complete online measures

You may not qualify if:

  • Cognitive impairments (as assessed by reviewing medical chart and consultation with the patient's rheumatologist)
  • Major co-morbid illnesses (e.g., medical \[inflammatory bowel disease, cancer, diabetes\] or psychiatric \[depression, anxiety\]) which may impact their ability to understand and use the game or complete outcome assessments (as determined by their rheumatologist).
  • Children currently participating in other Cognitive Behavioural Therapy (CBT) interventions
  • Usability testing participants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

BC Children's Hospital

Vancouver, British Columbia, Canada

Location

IWK Health Centre

Halifax, Nova Scotia, Canada

Location

Children's Hospital

London, Ontario, Canada

Location

Children's Hospital of Eastern Ontario

Ottawa, Ontario, Canada

Location

The Hospital for Sick Children

Toronto, Ontario, Canada

Location

CHU Sainte-Justine

Montreal, Quebec, Canada

Location

Montreal Children's Hospital

Montreal, Quebec, Canada

Location

MeSH Terms

Conditions

Arthritis, Juvenile

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinician Scientist/Clinical Nurse Specialist/NP

Study Record Dates

First Submitted

November 17, 2015

First Posted

November 20, 2015

Study Start

January 1, 2016

Primary Completion

March 1, 2019

Study Completion

March 1, 2019

Last Updated

June 18, 2019

Record last verified: 2019-06

Locations